Geir Harald Mjøen
Position:
Phone:
Email:
 

Author network for Geir Harald Mjøen by COREMINE medical


Publications 2017

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation (in press)
PubMed 28207636

Holdaas H, Mjøen G, Jardine AG (2017)
Belatacept: Where the BENEFITS Outweigh the Risk
Am J Kidney Dis, 69 (5), 561-563
PubMed 28434523

Meyer KB, Hartmann A, Mjøen G, Andersen MH (2017)
Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
Ann Transplant, 22, 148-155
PubMed 28321111

Mjoen G, Holdaas H (2017)
LIVING KIDNEY DONATION Long term risk of mortality after living kidney donation
BMJ-British Medical Journal, 357, j1770

Mjøen G, Holdaas H (2017)
Long term risk of mortality after living kidney donation
BMJ, 357, j1770
PubMed 28442509

Mjøen G, Holdaas H (2017)
Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors"
Kidney Int, 91 (5), 1256
PubMed 28407879

Norby GE, Mjøen G, Bjørneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarød K (2017)
Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry
Lupus, 26 (8), 881-885
PubMed 28059018

Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
Transpl Int, 30 (8), 827-840
PubMed 28436117

Publications 2016

Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
Clin Transplant, 30 (7), 802-9
PubMed 27101801

Mjoen G, Reisaeter AV, Dahle DO (2016)
HLA Mismatch and Allograft Survival
Transplantation, 100 (9), e52
PubMed 27399204

Mjøen G, Holdaas H (2016)
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
N Engl J Med, 374 (21), 2094
PubMed 27223156

Mjøen G, Holdaas H (2016)
Regarding long-term outcome after kidney donation
Transpl Int, 29 (3), 381
PubMed 26563683

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 31 (1), 170
PubMed 26740671

Pihlstrøm HK, Mjøen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellström B, Holdaas H, Melum E (2016)
Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study
Am J Transplant, 17 (2), 528-533
PubMed 27483393

Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
BMC Nephrol, 17 (1), 148
PubMed 27760523

Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
Am J Transplant, 17 (1), 265-271
PubMed 27341702

Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2016)
Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
Nephrol Dial Transplant (in press)
PubMed 27798199

Publications 2015

Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Transplantation, 99 (8), 1730-7
PubMed 25757216

Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
Clin Transplant, 29 (3), 268-76
PubMed 25644963

Mjøen G, Holdaas H (2015)
The authors reply:
Kidney Int, 87 (3), 660
PubMed 25723634

Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H (2015)
Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism
Transplantation, 99 (2), 351-9
PubMed 25594550

Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
Transplantation, 99 (4), 791-6
PubMed 25222012

Publications 2014

Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin Transplant, 28 (10), 1167-76
PubMed 25124959

Holdaas H, Mjoen G (2014)
Long-term risks of kidney donation: age known
Am J Transplant, 14 (11), 2671-2
PubMed 25293790

Mjøen G (2014)
The author replies
Kidney Int, 85 (6), 1469
PubMed 24875550

Mjøen G, Hallan S, Dekker FW, Holdaas H (2014)
The authors reply
Kidney Int, 86 (3), 650
PubMed 25168504

Mjøen G, Hallan S, Holdaas H (2014)
The authors reply:
Kidney Int, 85 (5), 1241-2
PubMed 24786884

Mjøen G, Holdaas H (2014)
Selecting appropriate controls for kidney donors
Am J Transplant, 15 (1), 286
PubMed 25363214

Mjøen G, Holdaas H (2014)
The authors reply
Kidney Int, 86 (2), 447
PubMed 25079028

Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
Transplantation, 98 (11), 1219-25
PubMed 24999963

Publications 2013

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin Transplant, 28 (1), 134-40
PubMed 24372653

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
Endothelial dysfunction is associated with graft loss in renal transplant recipients
Transplantation, 95 (5), 733-9
PubMed 23364481

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
PubMed 24284516

Pihlstrøm H, Mjøen G, März W, Olav Dahle D, Abedini S, Holme I, Fellström B, Jardine A, Pilz S, Holdaaas H (2013)
Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
Clin Transplant, 28 (1), 111-9
PubMed 24372612

Schjelderup P, Dahle DO, Holdaas H, Mjøen G, Nordby G, Abedini S, Jardine A, Fellström B, Svensson M (2013)
Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study
Clin Transplant, 27 (6), E636-43
PubMed 23991916

Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin Transplant, 28 (1), 120-6
PubMed 24351078

Publications 2011

Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
Inflammation-associated graft loss in renal transplant recipients
Nephrol Dial Transplant, 26 (11), 3756-61
PubMed 21511816

Mjøen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
Age, gender, and body mass index are associated with renal function after kidney donation
Clin Transplant, 25 (6), E579-83
PubMed 21906171

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 27 (1), 443-7
PubMed 21636826

Mjøen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
Quality of life in kidney donors
Am J Transplant, 11 (6), 1315-9
PubMed 21486387

Norby GE, Günther A, Mjøen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
Rheumatology (Oxford), 50 (9), 1659-64
PubMed 21624893

Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
Arthritis Rheum, 63 (3), 733-7
PubMed 21360503

Svensson M, Dahle DO, Mjøen G, Weihrauch G, Scharnagl H, Dobnig H, März W, Jardine A, Fellström B, Holdaas H (2011)
Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study
Nephrol Dial Transplant, 27 (6), 2571-5
PubMed 22172725

Publications 2010

Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
One- and five-year follow-ups on blood pressure and renal function in kidney donors
Transpl Int, 24 (1), 73-7
PubMed 20723180

Mjøen G, Holdaas H, Pfeffer P, Line PD, Øyen O (2010)
Minimally invasive living donor nephrectomy - introduction of hand-assistance
Transpl Int, 23 (10), 1008-14
PubMed 20412538

Publications 2009

Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
Transplantation, 88 (11), 1273-9
PubMed 19996926